Use of drugs against osteoporosis in the Baltic countries during 2010 –2014

Conclusions The differences in consumption of drugs against osteoporosis in the Baltic countries are not very big. The consumption of antiosteoporotic drugs is not to be regarded as sufficient though. The generally low consumption of osteoporotic medicines in the Baltic countries can be attributed to the overall less than EU average wealth of the countries and less than optimal expenditure on healthcare out of the GDP.
Source: Medicina - Category: Journals (General) Source Type: research